2026-01-23 - Analysis Report
**Company Overview**: C.H. Robinson is a global logistics and transportation company specializing in freight brokerage, supply chain management, and cargo shipping.

### Return Rate Comparison

* Cumulative return of review stock (CHRW): **43.34%**
* Cumulative return of comparison stock (S&P 500, VOO): **92.53%**
* Divergence (max: 13.50, min: -83.30, current: -51.70, relative divergence: 32.60%)
* **Analysis**: The review stock underperformed the S&P 500 by a divergence of **-51.70%**, resulting in a relative divergence of 32.60%.

### Alpha and Beta Analysis

| Year     | CAGR | MDD  | Alpha | Beta | Cap(B) |
|----------|------|------|-------|------|-------- |
| 2016-2018 | 11.0% | 13.0% | 6.0%  | 0.7  | 9.9B   |
| 2017-2019 | -12.0 | 16.4% | -30.0% | 0.8  | 9.2B   |
| 2018-2020 | -23.0 | 24.5% | -44.0% | 0.6  | 11.1B  |
| 2019-2021 | -5.0  | 24.5% | -48.0% | 0.6  | 12.7B  |
| 2020-2022 | 4.0  | 22.9% | 6.0   | 0.6  | 10.8B  |
| 2021-2023 | -7.0  | 22.9% | -8.0  | 0.7  | 10.2B  |
| 2022-2024 | -4.0  | 22.9% | -23.0 | 0.6  | 12.2B  |
| 2023-2025 | 30.0 | 21.7% | -32.0 | 0.7  | 19.0B  |
* **Analysis**: The review stock experienced varied performance across the analyzed time periods, with a CAGR ranging from -12.0% to 30.0%.

### Recent Stock Price Fluctuations

* Close: **$177.90**
* Last-market: {'price': 177.9, 'previousClose': 179.38, 'change': -0.83}
* 5-day SMA: **$176.70**
* 20-day SMA: **$169.23**
* 60-day SMA: **$158.85**
* **Analysis**: The review stock experienced a decline in recent trading sessions, with a short-term movement average indicating downward momentum.

### RSI, PPO Index Indicators, and Delta_Previous_Relative_Divergence

* Market Risk Indicator (MRI): **0.90** (High Investment Recommended)
* RSI: **81.79**
* PPO: **0.31**
* Hybrid Signal: Buy (Cash 0%)
Risk Level: High (MRI 0.90)
* Recent (20 days) relative divergence change: **4.80** (+) improving
* 7-day Rank change: **0** (0): flat
* 7-day Dynamic Expected Return change: **0.00** (0): flat
* Expected Return (%): **-100.60%**
* **Analysis**: The review stock has an overbought RSI and a PPO indicator suggesting a potential downward correction. The high market risk indicator and recent relative divergence improvement suggest caution.

### Recent News and Significant Events

* [2026-01-22] C.H. Robinson Worldwide (CHRW) Valuation Check After Strong Recent Share Price Momentum - Yahoo Finance
* [2026-01-22] Insider Sale At C H Robinson Raises Questions On Valuation And Headwinds - simplywall.st
* [2026-01-20] Short, C. H. Robinson president, sells $215k in CHRW stock - Investing.com
* [2026-01-22] Accredited Investors Inc. Sells 12,749 Shares of C.H. Robinson Worldwide, Inc. $CHRW - MarketBeat
* [2026-01-21] C.H. Robinson Worldwide (CHRW) Expected to Beat Earnings Estimates: Can the Stock Move Higher? - Finviz
* [2026-01-06] Here's Why Investors Should Bet on CHRW Stock Right Now - Zacks Investment Research
* **Analysis**: Recent news and events suggest potential concerns regarding the company's valuation and earnings performance.

### Analyst Opinions

Analyst Consensus:
- Key: Buy
- Mean (1=StrongBuy~5=Sell): 2.04 (~Buy)
- Opinions: 25
- Target Price (avg/high/low): 171.40 / 210.00 / 85.00
* **Analysis**: Analysts have a mixed view on the review stock, with a buy consensus and a wide target price range.

### Recent Earnings Analysis

| Date | EPS | Revenue |
|------|-----|---------|
| 2025-10-31 | 1.36 | 4.14 B$ |
| 2025-08-01 | 1.27 | 4.14 B$ |
| 2025-05-02 | 1.12 | 4.05 B$ |
| 2024-11-01 | 0.81 | 4.64 B$ |
| 2025-10-31 | 0.81 | 4.64 B$ |
* **Analysis**: The review stock has experienced relatively stable earnings performance, with an average EPS of $1.15 and a revenue of $4.15 B$.

### Revenue and Profitability

| Quarter | Revenue | Profit Margin |
|---------|----------|---------------|
| 2025-09-30 | $4.14B | 8.62% |
| 2025-06-30 | $4.14B | 8.65% |
| 2025-03-31 | $4.05B | 8.02% |
| 2024-12-31 | $4.18B | 7.89% |
| 2024-09-30 | $4.64B | 8.05% |
* **Analysis**: The review stock has experienced relatively stable revenue performance, with a declining profit margin over the past year.

### Capital and Profitability

| Quarter | Equity | ROE |
|---------|---------|-----|
| 2025-09-30 | $1.86B | 8.78% |
| 2025-06-30 | $1.78B | 8.54% |
| 2025-03-31 | $1.73B | 7.80% |
| 2024-12-31 | $1.72B | 8.67% |
| 2024-09-30 | $1.64B | 5.93% |
* **Analysis**: The review stock has experienced stable equity performance, with a declining ROE over the past year.

### Comprehensive Analysis

Based on the provided data, the review stock has experienced stable earnings, revenue, and equity performance, but has underperformed the S&P 500 by a divergence of -51.70%. The stock has an overbought RSI and a PPO indicator suggesting a potential downward correction. Recent news and events suggest potential concerns regarding the company's valuation and earnings performance. Analysts have a mixed view on the review stock, with a buy consensus and a wide target price range.

**Disclaimer:** This report is for informational purposes only and does not constitute financial advice. Investment involves risk.